<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zou Y</submitter><funding>Xiaogan City Natural Science Program Project</funding><pagination>93-105</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11909710</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>72(1)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Accurate identification and grading of clinically significant prostate cancer (csPCa, Gleason Score ≥ 7) without invasive procedures remains a significant clinical challenge. This study aims to develop and evaluate a two-stage model designed for precise Gleason grading. The model initially uses radiomics-based multiparametric MRI to identify csPCa and then refines the Gleason grading by integrating clinical indicators and radiomics features.&lt;h4>Methods&lt;/h4>We retrospectively analysed 399 patients with PI-RADS ≥ 3 lesions, categorising them into non-significant prostate cancer (nsPCa, 263 cases) and csPCa (136 cases, subdivided by GGs). Regions of interest (ROIs) for the prostate and lesions were manually delineated on T2-weighted and apparent diffusion coefficient (ADC</pubmed_abstract><journal>Journal of medical radiation sciences</journal><pubmed_title>A two-stage model for precise identification and Gleason grading of clinically significant prostate cancer: a hybrid approach.</pubmed_title><pmcid>PMC11909710</pmcid><funding_grant_id>XGKJ2024010035</funding_grant_id><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Zou Y</pubmed_authors><pubmed_authors>Xie Y</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Cui J</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Tian R</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Jiao C</pubmed_authors><pubmed_authors>Kang Z</pubmed_authors><pubmed_authors>Ma F</pubmed_authors></additional><is_claimable>false</is_claimable><name>A two-stage model for precise identification and Gleason grading of clinically significant prostate cancer: a hybrid approach.</name><description>&lt;h4>Introduction&lt;/h4>Accurate identification and grading of clinically significant prostate cancer (csPCa, Gleason Score ≥ 7) without invasive procedures remains a significant clinical challenge. This study aims to develop and evaluate a two-stage model designed for precise Gleason grading. The model initially uses radiomics-based multiparametric MRI to identify csPCa and then refines the Gleason grading by integrating clinical indicators and radiomics features.&lt;h4>Methods&lt;/h4>We retrospectively analysed 399 patients with PI-RADS ≥ 3 lesions, categorising them into non-significant prostate cancer (nsPCa, 263 cases) and csPCa (136 cases, subdivided by GGs). Regions of interest (ROIs) for the prostate and lesions were manually delineated on T2-weighted and apparent diffusion coefficient (ADC</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-04-20T00:11:30.558Z</modification><creation>2025-04-20T00:11:30.558Z</creation></dates><accession>S-EPMC11909710</accession><cross_references><pubmed>39698957</pubmed><doi>10.1002/jmrs.841</doi></cross_references></HashMap>